Literature DB >> 15009001

Adipokine levels in Cushing's syndrome; elevated resistin levels in female patients with Cushing's syndrome.

Michal Krsek1, Josef V Silha, Jana Jezková, Václav Hána, Josef Marek, Vladimír Weiss, Jan J Stepán, Liam J Murphy.   

Abstract

BACKGROUND: Cushing's syndrome (CS) is associated with central adiposity, insulin resistance and impaired glucose homeostasis. Adipose tissue is thought to regulates glucose homeostasis via circulating adipokines, such as resistin, leptin and adiponectin, although their role in the insulin resistance associated with CS has not been established.
DESIGN: We examined the relationship between insulin resistance and adipokine levels in CS patients. We compared plasma levels of resistin, leptin and adiponectin in 10 women and four men patients with CS, with 14 health subjects matched for age, gender and body mass index. A subgroup of three women and four men with pituitary-dependent CS were re-examined at least 9 months after curative surgery.
RESULTS: CS patients had significantly more truncal fat and less lean body mass as assessed by DEXA compared to control subjects. Total cholesterol, triglycerides and insulin resistance, as calculated using the homeostasis model assessment of insulin resistance (HOMA-R), was significantly increased in CS patients. Of the adipokines measured, only resistin was significantly different between female CS patients and female control subjects (5.05 +/- 0.56 vs. 2.91 +/- 0.39 micro g/l, P = 0.015). Curative surgery significantly reduced total body fat and truncal fat, leptin, total and low-density lipoprotein (LDL) cholesterol, glucose and HOMA-R. A reduction in both resistin and adiponectin was also observed but the differences between pre- and post-treatment levels did not achieve statistical significance.
CONCLUSION: Here we report for the first time that resistin levels are significantly elevated in CS patients and may be important in the insulin resistance associated with glucocorticoid excess.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15009001     DOI: 10.1111/j.1365-2265.2003.01987.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  12 in total

Review 1.  Characterization of persistent and recurrent Cushing's disease.

Authors:  Nina K Sundaram; Alessia Carluccio; Eliza B Geer
Journal:  Pituitary       Date:  2014-08       Impact factor: 4.107

Review 2.  Glucocorticoid effects on adiponectin expression.

Authors:  Siddharth Sukumaran; Debra C Dubois; William J Jusko; Richard R Almon
Journal:  Vitam Horm       Date:  2012       Impact factor: 3.421

3.  MRI assessment of lean and adipose tissue distribution in female patients with Cushing's disease.

Authors:  Eliza B Geer; Wei Shen; Dympna Gallagher; Mark Punyanitya; Helen C Looker; Kalmon D Post; Pamela U Freda
Journal:  Clin Endocrinol (Oxf)       Date:  2010-10       Impact factor: 3.478

Review 4.  Clinical consequences of Cushing's syndrome.

Authors:  Elena Valassi; Iris Crespo; Alicia Santos; Susan M Webb
Journal:  Pituitary       Date:  2012-09       Impact factor: 4.107

Review 5.  Clinical and biochemical manifestations of Cushing's.

Authors:  Georgia Ntali; Ashley Grossman; Niki Karavitaki
Journal:  Pituitary       Date:  2015-04       Impact factor: 4.107

6.  Correction of cortisol overreplacement ameliorates morbidities in patients with hypopituitarism: a pilot study.

Authors:  Karina Danilowicz; Oscar Domingo Bruno; Marcos Manavela; Reynaldo Manuel Gomez; Ariel Barkan
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

Review 7.  Cushing's Disease - Quality of Life, Recurrence and Long-term Morbidity.

Authors:  Isabel Huguet; Georgia Ntali; Ashley Grossman; Niki Karavitaki
Journal:  Eur Endocrinol       Date:  2015-04-11

8.  Steroid replacement in primary adrenal failure does not appear to affect circulating adipokines.

Authors:  Marta Fichna; Piotr Fichna; Maria Gryczyńska; Agata Czarnywojtek; Magdalena Żurawek; Marek Ruchała
Journal:  Endocrine       Date:  2014-08-17       Impact factor: 3.633

Review 9.  Metabolic disturbances connecting obesity and depression.

Authors:  Cecile Hryhorczuk; Sandeep Sharma; Stephanie E Fulton
Journal:  Front Neurosci       Date:  2013-10-07       Impact factor: 4.677

Review 10.  Mood, food, and obesity.

Authors:  Minati Singh
Journal:  Front Psychol       Date:  2014-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.